4//SEC Filing
NPS PHARMACEUTICALS INC 4
Accession 0000890465-14-000030
CIK 0000890465operating
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 8:30 PM ET
Size
8.9 KB
Accession
0000890465-14-000030
Insider Transaction Report
Form 4
STRATEMEIER ED
SVP & Acting GC
Transactions
- Exercise/Conversion
Common Stock
2014-02-13+5,670→ 46,204 total - Tax Payment
Common Stock
2014-02-13$38.30/sh−1,951$74,723→ 44,253 total - Exercise/Conversion
Restricted Stock Units
2014-02-13−5,670→ 11,341 totalExercise: $0.00→ Common Stock (5,670 underlying)
Footnotes (3)
- [F1]Each vested Restricted Stock Unit is the economic equivalent of one share of common stock of NPS Pharmaceuticals, Inc. (the "Issuer"). The vested Restricted Stock Units were settled for shares of the Issuer's common stock.
- [F2]Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to statisfy tax obligations arising from the vesting of the Restricted Stock Units described in this Form 4.
- [F3]On February 13, 2013, the Restricted Stock Units were granted with one third vesting on the first anniversary of the date of grant, one third vesting on the second anniversary of the date of grant and the remaining vesting on the third anniversary of the date of grant. As of the date of this filing, 5,670 of the Restricted Stock Units have vested.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000890465
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 8:30 PM ET
- Size
- 8.9 KB